🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

CannTrust CEO Loses Job, $6 Million in Options: Cannabis Weekly

Published 07/29/2019, 06:00 PM
Updated 07/29/2019, 08:14 PM
CannTrust CEO Loses Job, $6 Million in Options: Cannabis Weekly
BARC
-
CSGN
-
IMB
-
MO
-
TSLA
-

(Bloomberg) -- Peter Aceto didn’t just lose his job as head of CannTrust Holdings Inc.: he likely lost out on about C$8.2 million ($6.2 million) in stock options, among the highest pay packages in the pot sector.

CannTrust fired Aceto, and chairman Eric Paul was asked to resign Thursday after a Globe and Mail report cited internal emails showing the executives were aware that pot was being grown in unlicensed rooms about seven months before Health Canada unearthed the breach.

Aceto’s stock options will likely be canceled, as typically happens when an executive is fired with cause. Even if they’re not canceled, the options remain well under water following the recent stock plunge related to the licensing scandal.

According to the options awarded to Aceto when he joined the company in October, a third were to be vested annually in one-third increments, with two-thirds to be vested based on achieving share price milestones of C$15 to C$25 over three years. CannTrust traded at about C$3 on Friday, well short of Aceto’s strike price of C$11.88 for his 1 million options.

Aceto’s pay package trailed Brendan Kennedy among major pot company executives. The Tilray Inc. CEO was awarded total compensation of $256 million in 2018, ranking him second to Tesla (NASDAQ:TSLA) Inc.’s Elon Musk at $513 million, among pay tracked by Bloomberg. By comparison, former Canopy Growth Ltd. CEO Bruce Linton was awarded C$2.5 million and Michael Gorenstein at Cronos Group Inc. was granted C$824,842. Terry Booth at Aurora Cannabis Inc. was awarded C$1.6 million, according to company filings.

Extractors Rally

Cannabis extractors have posted outsized share gains this year, and analysts remain bullish on the sub-sector.

Key players include MediPharm Labs Corp., Valens Groworks Corp., and Neptune Wellness Solutions Inc. All three have seen their stock more than double since the start of 2019.

“Extraction will be in high demand as additional cultivation comes online, with Valens poised to be a leading player,” Eight Capital analyst Jenny Wang told clients in a note. The investment bank initiated stock coverage with a buy recommendation and price target of C$8.25.

Retail’s ‘Magic Number’

One Wall Street bank attempted to estimate how many pot dispensaries may be needed across North America to garner optimal legal sales. The magic number: about three dispensaries per 100,000 people, Seaport Global Securities LLC said in a note. The New York-based investment bank reviewed dispensary counts by state and province across North America, along with data available on industry sales receipts.

In Canada, it’s no secret the nation’s store roll-out has been slower than expected in the two most populated provinces of Ontario and Quebec. “Based upon our rule of three, we would argue that Ontario needs a total footprint of 403 stores,” up from the current figure of about 23. Additionally, Seaport estimated Quebec needs a total footprint of 245 stores, up from about 16, analyst Brett Hundley wrote. In all, Canada may need around 1,055 pot stores for the industry to see its true potential, Seaport added.

Equity Offering Litmus Test

Flowr Corp. may have given investors an indication of appetite for equity offerings. The pot producer announced a C$43.5 million bought-deal financing last week, shortly after withdrawing an equity offering the prior week. Shares surged 21% after the pulled offering, though fell 17% after the bought-deal July 22. Toronto-based GMP Securities LP is lead underwriter for the sale, which is expected to close Aug. 8. The original share offering included Barclays (LON:BARC), BMO Capital Markets and Credit Suisse (SIX:CSGN).

Deals

Two deals catching eyes last week included Auxly Cannabis Group Inc. getting an investment from U.K. cigarette maker Imperial Brands (LON:IMB) Plc as the companies move to position themselves for the expansion of cannabis-based vaping products in Canada.

The deal is a “major positive for Auxly’s shareholders,” AltaCorp Capital analyst David Kideckel said in a note to clients. Auxly is now “one of two cannabis companies to have signed a major deal with a global tobacco company, the other one being Cronos,” he added.

Additionally, convenience-store giant Alimentation Couche-Tard Inc., the owner of Circle K stores, announced an investment in pot retailer Fire & Flower Holdings Corp. It’s a “vote of confidence from a large multi-national retailer in Fire & Flower’s ability to rapidly scale its retail platform,” Eight Capital told clients in a note.

Upcoming Events

TUESDAY 7/30

  • Altria Group (NYSE:MO) Inc., which owns 45% of Cronos Group, reports earnings pre-market with an analyst call at 9 a.m.
THURSDAY 8/1

  • Aphria Inc. to report earnings after the close; CIBC downgraded its recommendation to underperform on Friday, citing “concerns about aggressive Street estimates”
    • Earnings call at 5pm (888)-231-8191 pw 5081017
  • CannaFarm Con in San Diego, California through Aug. 2 (link: https://cannafarmcon.com/)
FRIDAY 8/2

  • Koi CBD hosts the USA CBD Expo in Miami Beach, Florida through Aug. 4
The Week’s Top Stories

CannTrust Jumps After Firing CEO Amid Breach at Cannabis Company

It’s Getting Harder to Fire People for Using Marijuana

Thailand Is Poised to Take an Early Lead in the Cannabis Race

Cannabis Draws More U.S. Bankers as Deals Flow Away from Canada

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.